Objective
Microbubbles are an established ultrasound contrast agent; detecting them with Magnetic Resonance Imaging (MRI) would open up a wide spectrum of dual-modality applications such as MR-guided focused ultrasound therapies. So far, MRI has been used to qualitatively assess the concentration of microbubbles based on a decrease in the MRI signal magnitude, which is difficult to differentiate from other sources of signal drop-out. In this fellowship, I will exploit quantitative susceptibility mapping (QSM), a novel approach, to detect microbubbles using MRI. QSM uses the phase, instead of the magnitude, of the complex MRI signal, which promises to enhance MRI of microbubbles because phase images have higher contrast-to-noise ratio than standard magnitude images. With the supervision and mentorship of Dr Karin Shmueli, an MRI physicist and internationally recognized expert in QSM, I will investigate the ability of QSM to quantify microbubble concentrations. Collaborating with Prof. Eleanor Stride, a leader in microbubble engineering, I will tailor the susceptibility of microbubbles for different clinical applications so that microbubbles will create bright contrast in susceptibility maps, clearly distinguishable from anatomical structures and image artifacts. This project will enhance the clinical applicability of microbubbles as a dual-modality, MRI and ultrasound, contrast agent. QSM of microbubbles has the potential to improve MRI guidance and monitoring of microbubble-mediated drug, antibody or gene delivery as well as microbubble-enhanced focused ultrasound surgery, which is currently in use for treating uterine fibroids and bone metastases. This fellowship will be a springboard towards widespread diagnostic and therapeutic applications of QSM of microbubbles. The unique training and skills provided by the fellowship will help me to establish my own research group and share the expertise I build in QSM and contrast agents with academic and industrial partners.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine surgery
- engineering and technology medical engineering diagnostic imaging magnetic resonance imaging
- natural sciences physical sciences acoustics ultrasound
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF-EF-ST - Standard EF
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
WC1E 6BT LONDON
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.